Caricamento...

A Public Health Approach to the Prevention of Inhibitors in Hemophilia

The development of an antibody in people with hemophilia to products used in the treatment and prevention of bleeding, also referred to as an inhibitor, is the most serious complication of hemophilia care today. CDC, together with healthcare providers, consumer organizations, hemophilia organization...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Am J Prev Med
Autori principali: Soucie, J. Michael, Miller, Connie H., Kelly, Fiona M., Oakley, Meredith, Brown, Deborah L., Kucab, Phillip
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4469363/
https://ncbi.nlm.nih.gov/pubmed/25245801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amepre.2014.07.007
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !